Thymoorgan-Hikma oncology (WE GIVE HOPE) launched Gemcitabine, Irinotecan, Vinorelbine, Epirubicin & Zoledronic acid Thymoorgan-Hikma oncology is dedicated to helping cancer patients by making effective therapies available to more and more patients and to decrease health care expenditures.